How do you approach treatment in a patient with a solitary plasmacytoma with minimal marrow involvement (< 10% clonal plasma cells)?  

Is there any data justifying the use of systemic therapy over localized therapy (e.g. radiation or surgery) in this situation prior to a progression event?



Answer from: Medical Oncologist at Academic Institution

Answer from: at Community Practice
Comments
Medical Oncologist at Gerard J Ventura MD, FACP
I recall @Bart Barlogie stated once (either formal...
Sign in or Register to read more